iron hydroxide adipate
Small moleculeexperimental
Clinical trial activity
6 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
1
Earliest trial started May 1, 2007 (NCT00479102)
Timeline
Indications
Approved for
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- iron hydroxide adipate
- iron hydroxide polymaltose complex
- magnesium iron hydroxycarbonate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06285799 | Phase 3 | Mar 5, 2024 | Nemysis Ltd, RDC Clinical Pty Ltd |
| NCT05950841 | Phase 3 | Jan 1, 2024 | RDC Clinical Pty Ltd |
| NCT03212677 | N/A | May 17, 2017 | Bill and Melinda Gates Foundation, Tufts University |
| NCT00841126 | Phase 3 | Jul 1, 2009 | Ineos Healthcare Limited |
| NCT01991574 | Early Phase 1 (Phase 1) | Apr 1, 2009 | Medical Research Council |
| NCT00479102 | Phase 4 | May 1, 2007 | Ben Gurion University, Technion University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RDC Clinical Pty Ltd | For profit | 2 | 1 | 1 | 2024 |
| Ben Gurion University | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Ineos Healthcare Limited | For profit | 1 | 1 | 1 | 2009 |
| Medical Research Council | Government | 1 | 1 | 1 | 2009 |
| Nemysis Ltd | For profit | 1 | 1 | 1 | 2024 |
| Technion University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Tufts University | Academic/Hospital | 1 | 1 | 1 | 2017 |
8 organizations
Page 1 / 1